Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celgene At $100: Buy, Sell, or Hold?

TheMotleyFool

0 0

It's been a rotten couple of weeks to be a shareholder of Celgene (NASDAQ: CELG). The biotech giant's shares have been in near-freefall after they reached an all-time high of $147 on Oct. 2. Investors who bought at the peak have lost more than 33% in a matter of weeks. Ouch.

A drop of that magnitude begs the question: Should investors buy the dip, or is the bull case for owning this stock busted?

Image source: Getty Images.

Source: Fool.com